Thu, Oct 23, 2014, 6:09 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Regeneron Pharmaceuticals, Inc. Message Board

peendee 2 posts  |  Last Activity: Sep 29, 2014 12:00 AM Member since: Jul 16, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • peendee by peendee Sep 29, 2014 12:00 AM Flag

    anything new from the restatement front?

  • peendee by peendee Jul 28, 2014 10:23 PM Flag

    Any company with 20%+ revenue growth for 2 consecutive years trades for 30x's earnings in this market in most industries. The stock is still stupid cheap if next year comes in at $400 mm revs and $2 in eps. I think the p/e should be at least 20x's. Look at cos like txn or adi or avgo. They trade at 20x's and have flat revs, well at least 2 of the 3 do. Since this is a major play on wireless device growth as well as the 4g build out, its conceptual appeal should have it at the top of the p/e list for semi stocks, imho.

REGN
393.96+9.50(+2.47%)Oct 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.